Meet the Veristat team at ASCO, May 31st to June 4th in Chicago
2024 ASCO Annual Meeting
May 3, 2024
Swiss Biotech Day
March 19, 2024
Meet Veristat in Basel at the Swiss Biotech Day, 22-23 April 2024
Cell & Gene Meeting on the Med 2024, an ARM Conference
March 11, 2024
Meet Veristat in Rome at the Meeting on the Med Conference 2024, 9-11 April 2024
Sponsored Webcast: Planning for a Successful Initial IND and Moving Beyond: Regulatory CMC Considerations for Biotherapeutics and Cell and Gene Therapies
Tuesday, 19 Sep 2023 | 11:00 AM Eastern Time (US & Canada)
Veristat and CITELINE hosted a webinar on the topic: Single-Arm Studies for Use as a Registrational Study in Oncology
Webinar | Impact of New Medical Device EU Regulation (MDR) on the Development of Drug-Device Combination Products
May 10, 2023
Veristat and TOPRA hosted a webinar on the topic: Impact of New EU Regulations on the Development of Medical Devices and Drug Combination Products
Marcus Evans Evolution Summit May 2023
April 20, 2023
Meet with Shaheen Limbada, EVP Innovation and Strategy at the Evolution Summit
ASGCT Annual Meeting 2023
April 18, 2023
Veristat’s John Balser, PhD., will be presenting in the scientific symposium
DIA Global Annual Meeting 2023
April 3, 2023
Attend our Innovation Theater Presentation on Decentralized Clinical Trials
Veristat and TOPRA hosted a new updated content webinar on the topic: Future Trends on European Regulations on Medicines
What You Will Learn
The European Commission announced on 25 November 2020 the adoption of the new Pharmaceutical Strategy for Europe. It is an approach intended to ensure strong, fair competitivity and green industry, fostering patient access to innovative and affordable medicines. It will ensure an autonomous and robust supply chain and a stronger EU voice at the global level by promoting a high level of quality, efficacy and safety standards.